Progesterone (micronised) (Utrogestan®)

Assessment Status Rapid Review Complete
Drug Progesterone (micronised)
Brand Utrogestan®
Indication Progesterone (micronised) is indicated in women for supplementation of the luteal phase during ART cycles.
Assessment Process
Rapid review commissioned 14/10/2019
Rapid review completed 20/11/2019
Rapid review outcome A full HTA is not recommended. The NCPE recommends that progesterone (micronised) be considered for reimbursement.*

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.